U.S. federal trademark · Serial No. 85516259 · Reg. No. 4400892
Pharmaceutical products, drug discovery and drug delivery agents consisting of compounds for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.